ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
189,00
0,00
( 0,00% )
Aktualisiert: 07:40:02

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
189,00
Gebot
176,00
Fragen
190,00
Volumen
0,00
0,00 Tagesbereich 0,00
148,00 52-Wochen-Bereich 202,00
Marktkapitalisierung
Handelsende
189,00
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
-
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
13
Ausgegebene Aktien
4.150.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
27,78
Gewinn pro Aktie (EPS)
6,8
Erlöse
362,44M
Nettogewinn
28,24M

Über Spadel SA

Sektor
Btld & Can Soft Drinks,water
Branche
Btld & Can Soft Drinks,water
Website
Hauptsitz
Brussels, Brussels-capital Region, Bel
Gegründet
1980
Spadel SA is listed in the Btld & Can Soft Drinks,water sector of the Euronext with ticker SPA. The last closing price for Spadel was 189,00 €. Over the last year, Spadel shares have traded in a share price range of 148,00 € to 202,00 €.

Spadel currently has 4.150.000 shares in issue. The market capitalisation of Spadel is 784,35 € million. Spadel has a price to earnings ratio (PE ratio) of 27.78.

SPA Neueste Nachrichten

Research Update

SR Pharma plc Research Update London 23 December 2003 - Corixa Corporation (Corixa) and Genesis Research and Development Corporation Limited (Genesis) announced yesterday that they had...

Holding(s) in Company

SR Pharma plc Holding in Company London 16 December 2003 - SR Pharma plc ("the Company") was informed today by the Royal Bank of Scotland Group plc that the Royal Bank of Scotland Group plc and...

Research Update

SR Pharma plc and EiRx Therapeutics Ltd sign research deal `New molecules for potential cancer treatments' London, 1 December 2003 - SR Pharma and EiRx Therapeutics today announced that they...

Interim Results

SR PHARMA PLC UNAUDITED INTERIM RESULTS FOR THE 6 MONTHS ENDED 30 JUNE 2003 SR Pharma plc, the London based biopharmaceutical company, today announces its unaudited interim results for the six...

Start of AVAC phase II clinical trial

SR Pharma and Genesis Research Initiate Phase II Trial of AVAC(tm) in Childhood Eczema London and Auckland, 10 September 2003 - London-based biopharmaceutical company SR Pharma (LSE: SPA) and its...

Directorate Change

Death of non-executive director of SR Pharma plc London, 23 July 2003 - SR Pharma plc regretfully announces the death of Professor Tim Chard who was a non-executive director of the company...

Resignation

RNS Number:7085N SR Pharma PLC 18 July 2003 18th July, 2003 TO: CITY EDITORS FOR IMMEDIATE RELEASE SR Pharma plc Resignation of executive director SR Pharma plc today announces...

SR Pharma completes enrolment of asthma clinical trial

SR Pharma completes enrolment of phase II clinical trial for asthma London, UK. 24 June 2003*SR Pharma plc (LSE: SPA) today announces the completion of enrolment in its phase II European clinical...

CEO Appointment

SR Pharma Appoints Dr David Hill As Chief Executive Officer London, UK. 19 May 2003SR Pharma plc (LSE: SPA) announces the appointment today of Dr David Hill as Chief Executive Officer and a member...

AGM Statement

SR Pharma Annual General Meeting London, UK. 19 May 2003 At today's Annual General Meeting, Chairman Eric Boyle said: "SR Pharma retains a robust cash position and a well diversified product...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10018918918900DE
4137.386363636361761891764186.83333333DE
12-1-0.52631578947419019417513188.53239437DE
2631.6129032258118620217317194.02603929DE
523724.342105263215220214850168.01934524DE
15614817520214831166.90513817DE
260-7-3.57142857143196202148114185.07801439DE

SPA - Frequently Asked Questions (FAQ)

What is the current Spadel share price?
The current share price of Spadel is 189,00 €
How many Spadel shares are in issue?
Spadel has 4.150.000 shares in issue
What is the market cap of Spadel?
The market capitalisation of Spadel is EUR 784,35M
What is the 1 year trading range for Spadel share price?
Spadel has traded in the range of 148,00 € to 202,00 € during the past year
What is the PE ratio of Spadel?
The price to earnings ratio of Spadel is 27,78
What is the cash to sales ratio of Spadel?
The cash to sales ratio of Spadel is 2,16
What is the reporting currency for Spadel?
Spadel reports financial results in EUR
What is the latest annual turnover for Spadel?
The latest annual turnover of Spadel is EUR 362,44M
What is the latest annual profit for Spadel?
The latest annual profit of Spadel is EUR 28,24M
What is the registered address of Spadel?
The registered address for Spadel is AVENUE DE COMMUNAUTES 110, B-1200 BRUXELLES, BRUSSELS, BRUSSELS-CAPITAL REGION, 1200
What is the Spadel website address?
The website address for Spadel is www.spadel.com
Which industry sector does Spadel operate in?
Spadel operates in the BTLD & CAN SOFT DRINKS,WATER sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
MRNMersen
21,45 €
(10,68%)
31,45k
ALVERVergnet
0,0011 €
(10,00%)
631,56k
IVAInventiva
2,34 €
(8,33%)
12,31k
ALBKKBaikowski
17,30 €
(8,13%)
703
BIODSBiosynex DS
0,03 €
(7,91%)
5,01k
ALJXRArchos
0,1262 €
(-15,07%)
431,69k
ALNMRNamR SA
0,32 €
(-12,57%)
2,31k
ALNEVNeovacs
0,3489 €
(-9,94%)
505
PROACProactis SA
0,06 €
(-9,09%)
3,86k
ALARFAdeunis
0,77 €
(-8,11%)
172
ATOAtos SE
0,0022 €
(4,76%)
22,39M
ALCYBCybergun
0,0001 €
(0,00%)
2,18M
BCPBanco Comercial Portugues SA
0,5084 €
(-0,04%)
1,55M
ALHPIHopium SA
0,003 €
(-3,23%)
1,03M
ALVERVergnet
0,0011 €
(10,00%)
631,56k
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock